We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane Metered Dose Inhaler

- Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Emphysema | Chronic Bronchitis
- Completed

Study Title: A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)

Teva Identifier: ABM-AS-307

ClinicalTrials.gov Identifier: NCT01302587

Study Status: Completed

Trial Condition(s): Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Emphysema | Chronic Bronchitis

Interventions: Drug: Albuterol

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender: Female, Male

Age Range: 4 Years and older

Trial Duration: 03/01/2011 - 06/01/2011

Study Type

Observational